Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Research

Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women, Papua New Guinea, 2015–2017

Michelle J.L. ScoullarComments to Author , Philippe Boeuf, Elizabeth Peach, Ruth Fidelis, Kerryanne Tokmun, Pele Melepia, Arthur Elijah, Catriona S. Bradshaw, Glenda Fehler, Peter M. Siba, Simon Erskine, Elisa Mokany, Elissa Kennedy, Alexandra J. Umbers, Stanley Luchters, Leanne J. Robinson, Nicholas C. Wong, Andrew J. Vallely, Steven G. Badman, Lisa M. Vallely, Freya J.I. Fowkes, Christopher Morgan, William Pomat, Brendan S. Crabb, James G. BeesonComments to Author , and Healthy Mothers Healthy Babies Study Team1
Author affiliations: Burnet Institute, Melbourne, Victoria, Australia (M.J.L. Scoullar, P. Boeuf, E. Peach, R. Fidelis, K. Tokmun, P. Melepia, E. Kennedy, A.J. Umbers, S. Luchters, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); Burnet Institute, Kokopo, Papua New Guinea (M.J.L. Scoullar, P. Boeuf, E. Peach, R. Fidelis, K. Tokmun, P. Melepia, E. Kennedy, A.J. Umbers, S. Luchters, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); University of Melbourne, Melbourne (M.J.L Scoullar, P. Boeuf, C.S. Bradshaw, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); University of Papua New Guinea, Port Moresby, Papua New Guinea (A. Elijah); Melbourne Sexual Health Centre, Melbourne (C.S. Bradshaw, G. Fehler); Monash University, Melbourne (C.S. Bradshaw, S. Luchters, L.J. Robinson, N.C. Wong, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea (P.M. Siba, L.J. Robinson, A. Vallely, L.M. Vallely, W. Pomat); SpeeDx Pty Ltd, Sydney, New South Wales, Australia (S. Erskine, E. Mokany); Aga Khan University, Nairobi, Kenya (S. Luchters); Ghent University, Ghent, Belgium (S. Luchters); University of New South Wales, Sydney (A. Vallely, S.G. Badman, L.M. Vallely); James Cook University, Townsville, Queensland, Australia (L.M. Vallely)

Main Article

Figure 2

Sensitivity of syndromic management for sexually transmitted infections in pregnant women, East New Britain, Papua New Guinea, 2015–2017. Participants answered the standard question according to Papua New Guinea national guidelines “Do you currently have any abnormal vaginal discharge?” or the alternative question “Have you experienced any abnormal vaginal discharge earlier in the pregnancy or now?” (22). Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections diagnosed with GeneXpert (Cepheid, https://www.cepheid.com). RTI, reproductive tract infection; STI, sexually transmitted infection.

Figure 2. Sensitivity of syndromic management for sexually transmitted infections in pregnant women, East New Britain, Papua New Guinea, 2015–2017. Participants answered the standard question according to Papua New Guinea national guidelines “Do you currently have any abnormal vaginal discharge?” or the alternative question “Have you experienced any abnormal vaginal discharge earlier in the pregnancy or now?” (22). Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections diagnosed with GeneXpert (Cepheid, https://www.cepheid.com). RTI, reproductive tract infection; STI, sexually transmitted infection.

Main Article

References
  1. Newman  L, Rowley  J, Vander Hoorn  S, Wijesooriya  NS, Unemo  M, Low  N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10:e0143304. DOIPubMedGoogle Scholar
  2. World Health Organization. Report on global sexually transmitted infection surveillance, 2018. 2018 [cited 2019 Dec 9]. https://www.who.int/reproductivehealth/publications/stis-surveillance-2018
  3. Rowley  J, Vander Hoorn  S, Korenromp  E, Low  N, Unemo  M, Abu-Raddad  LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bulletin of the World Health Organization. 2019;97:548–62, 62A–62P. DOIGoogle Scholar
  4. van de Wijgert  JHHM, Jespers  V. The global health impact of vaginal dysbiosis. Res Microbiol. 2017;168:859–64. DOIPubMedGoogle Scholar
  5. Peebles  K, Velloza  J, Balkus  JE, McClelland  RS, Barnabas  RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46:304–11. DOIPubMedGoogle Scholar
  6. Cauchie  M, Desmet  S, Lagrou  K. Candida and its dual lifestyle as a commensal and a pathogen. Res Microbiol. 2017;168:802–10. DOIGoogle Scholar
  7. Donovan  B. Sexually transmissible infections other than HIV. Lancet. 2004;363:545–56. DOIPubMedGoogle Scholar
  8. Arol  OA, Over  M, Manhard  L, Holmes  KK. Sexually transmitted infections. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 315
  9. Thwaites  A, Flanagan  K, Datta  S. Non-HIV sexually transmitted infections in pregnancy. Obstetrics, Gynaecol Reprod Med. 2019;29:151–7. DOIGoogle Scholar
  10. Martin  DH, Manhart  LE, Workowski  KA. Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities. J Infect Dis. 2017;216(suppl_2):S427–30. DOIPubMedGoogle Scholar
  11. Lis  R, Rowhani-Rahbar  A, Manhart  LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61:418–26. DOIPubMedGoogle Scholar
  12. Sonnenberg  P, Ison  CA, Clifton  S, Field  N, Tanton  C, Soldan  K, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol. 2015;44:1982–94. DOIPubMedGoogle Scholar
  13. Baumann  L, Cina  M, Egli-Gany  D, Goutaki  M, Halbeisen  FS, Lohrer  G-R, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis. Sex Transm Infect. 2018;94:255–62. DOIPubMedGoogle Scholar
  14. Oakeshott  P, Hay  P, Taylor-Robinson  D, Hay  S, Dohn  B, Kerry  S, et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. BJOG. 2004;111:1464–7. DOIPubMedGoogle Scholar
  15. Harrison  MA, Harding-Esch  EM, Marks  M, Pond  MJ, Butcher  R, Solomon  AW, et al. Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection. Sex Transm Infect. 2019;95:522–8. DOIPubMedGoogle Scholar
  16. Machalek  DA, Tao  Y, Shilling  H, Jensen  JS, Unemo  M, Murray  G, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20:1302–14. DOIPubMedGoogle Scholar
  17. The World Bank Group. Papua New Guinea. 2019 [cited 2020 Feb 25]. https://data.worldbank.org/country/papua-new-guinea
  18. National Statistical Office of Papua New Guinea; ICF International, Inc. Papua New Guinea demographic and health survey 2016–18. 2019 [cited 2020 Aug 10]. https://www.nso.gov.pg/census-surveys/demographic-and-health-survey
  19. Robbers  G, Vogel  JP, Mola  G, Bolgna  J, Homer  CSE. Maternal and newborn health indicators in Papua New Guinea - 2008-2018. Sex Reprod Health Matters. 2019;27:1686199. DOIPubMedGoogle Scholar
  20. Vallely  LM, Toliman  P, Ryan  C, Rai  G, Wapling  J, Tomado  C, et al. Prevalence and risk factors of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and other sexually transmissible infections among women attending antenatal clinics in three provinces in Papua New Guinea: a cross-sectional survey. Sex Health. 2016;13:420–7. DOIPubMedGoogle Scholar
  21. Mola  G, Amoa  A, Bagita  M, Augerea  L, Geita  L, O’Connor  M. Manual of standard managements in obstetrics and gynaecology for doctors, HEOs and nurses in Papua New Guinea. 7th ed. Port Moresby (Papua New Guinea): World Health Organization; 2016. p. 10, 94.
  22. National Department of Health. Standard treatment guidelines for common illness of adults in Papua New Guinea. 6th ed. Port Moresby (Papua New Guinea): World Health Organization; 2012. p. 41–2.
  23. Vallely  A, Page  A, Dias  S, Siba  P, Lupiwa  T, Law  G, et al. The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis. PLoS One. 2010;5:e15586. DOIPubMedGoogle Scholar
  24. Golden  MR, Workowski  KA, Bolan  G. Developing a public health response to Mycoplasma genitalium. J Infect Dis. 2017;216(suppl_2):S420–6. DOIPubMedGoogle Scholar
  25. Jensen  JS, Cusini  M, Gomberg  M, Moi  H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30:1650–6. DOIPubMedGoogle Scholar
  26. Donders  GGG, Ruban  K, Bellen  G, Petricevic  L. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. J Perinat Med. 2017;45:505–15. DOIPubMedGoogle Scholar
  27. Deborde  M, Pereyre  S, Puges  M, Bébéar  C, Desclaux  A, Hessamfar  M, et al. High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program. Med Mal Infect. 2019;49:347–9. DOIPubMedGoogle Scholar
  28. Hoffman  CM, Mbambazela  N, Sithole  P, Morré  SA, Dubbink  JH, Railton  J, et al. Provision of sexually transmitted infection services in a mobile clinic reveals high unmet need in remote areas of South Africa: a cross-sectional study. Sex Transm Dis. 2019;46:206–12. DOIPubMedGoogle Scholar
  29. Cohen  CR, Nosek  M, Meier  A, Astete  SG, Iverson-Cabral  S, Mugo  NR, et al. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis. 2007;34:274–9. DOIPubMedGoogle Scholar
  30. Vandepitte  J, Muller  E, Bukenya  J, Nakubulwa  S, Kyakuwa  N, Buvé  A, et al. Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis. 2012;205:289–96. DOIPubMedGoogle Scholar
  31. Peuchant  O, Le Roy  C, Desveaux  C, Paris  A, Asselineau  J, Maldonado  C, et al. Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women? Diagn Microbiol Infect Dis. 2015;82:14–9. DOIPubMedGoogle Scholar
  32. Labbé  AC, Frost  E, Deslandes  S, Mendonça  AP, Alves  AC, Pépin  J. Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau. Sex Transm Infect. 2002;78:289–91. DOIPubMedGoogle Scholar
  33. Joshua  IB, Passmore  PR, Sunderland  BV. An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea. Health Policy Plan. 2016;31:538–46. DOIPubMedGoogle Scholar
  34. Wangnapi  RA, Soso  S, Unger  HW, Sawera  C, Ome  M, Umbers  AJ, et al. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect. 2015;91:194–200. DOIPubMedGoogle Scholar
  35. Badman  SG, Vallely  LM, Toliman  P, Kariwiga  G, Lote  B, Pomat  W, et al. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea. BMC Infect Dis. 2016;16:250. DOIPubMedGoogle Scholar
  36. Marks  M, Kako  H, Butcher  R, Lauri  B, Puiahi  E, Pitakaka  R, et al. Prevalence of sexually transmitted infections in female clinic attendees in Honiara, Solomon Islands. BMJ Open. 2015;5:e007276. DOIPubMedGoogle Scholar
  37. Vallely  LM, Toliman  P, Ryan  C, Rai  G, Wapling  J, Gabuzzi  J, et al. Performance of syndromic management for the detection and treatment of genital Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women attending antenatal, well woman and sexual health clinics in Papua New Guinea: a cross-sectional study. BMJ Open. 2017;7:e018630. DOIPubMedGoogle Scholar
  38. Unger  HW, Ome-Kaius  M, Wangnapi  RA, Umbers  AJ, Hanieh  S, Suen  CSNLW, et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. BMC Med. 2015;13:9. DOIPubMedGoogle Scholar
  39. Peters  RPH, Dubbink  JH, van der Eem  L, Verweij  SP, Bos  MLA, Ouburg  S, et al. Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis. 2014;41:564–9. DOIPubMedGoogle Scholar
  40. Moodley  D, Moodley  P, Sebitloane  M, Soowamber  D, McNaughton-Reyes  HL, Groves  AK, et al. High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis. 2015;42:43–7. DOIPubMedGoogle Scholar
  41. Pappas  PG, Kauffman  CA, Andes  D, Benjamin  DK Jr, Calandra  TF, Edwards  JE Jr, et al.; Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35. DOIPubMedGoogle Scholar
  42. Klufio  CA, Amoa  AB, Delamare  O, Hombhanje  M, Kariwiga  G, Igo  J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. P N G Med J. 1995;38:163–71.PubMedGoogle Scholar
  43. Sobel  JD. Vulvovaginal candidosis. Lancet. 2007;369:1961–71. DOIPubMedGoogle Scholar
  44. Lavu  EK, Johnson  K, Banamu  J, Pandey  S, Carter  R, Coulter  C, et al. Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017. Public Health Action. 2019;9(Suppl 1):S12–8. DOIPubMedGoogle Scholar
  45. Papua New Guinea National Department of Health. Sector performance annual review. Port Moresby (Papua New Guinea): Ministry of Health; 2018.
  46. Papua New Guinea National Department of Health. Sector performance annual review. Port Moresby (Papua New Guinea): Ministry of Health; 2016.
  47. Mitjà  O, Marks  M, Konan  DJP, Ayelo  G, Gonzalez-Beiras  C, Boua  B, et al. Global epidemiology of yaws: a systematic review. Lancet Glob Health. 2015;3:e324–31. DOIPubMedGoogle Scholar
  48. Mitjà  O, Godornes  C, Houinei  W, Kapa  A, Paru  R, Abel  H, et al. Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. Lancet. 2018;391:1599–607. DOIPubMedGoogle Scholar
  49. United Nations. SDG indicators: global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development. 2021 [cited 2021 Jan 14]. https://unstats.un.org/sdgs/indicators/indicators-list

Main Article

1Members of this group are listed at the end of this article.

Page created: January 11, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external